Literature DB >> 25586635

Microarray technology to investigate genes associated with papillary thyroid carcinoma.

Xinyong Zhu1, Jing Yao1, Wen Tian1.   

Abstract

DNA microarray data on thyroid tissue from patients with papillary thyroid carcinoma (PTC) and from healthy controls were compared in order to investigate the regulatory genes and uncover the underlying regulatory network in PTC. The DNA microarray data set, GSE3678, was downloaded from Gene Expression Omnibus database. This included seven thyroid tissue samples from patients with PTC and seven samples from healthy controls. Raw data were processed and differentially expressed genes (DEGs) were identified using corresponding R packages. Gene regulation analysis was conducted using TRANSFAC® and TRED. A total of 171 DEGs were obtained. A regulatory network was then established, using 104 of the DEGs. Subsequently, pathway enrichment analyses of the genes were conducted using Database for Annotation, Visualization and Integrated Discovery (DAVID) online tool. Three differentially expressed transcription factors were identified: Trefoil factor 3, cut‑like homeobox 2 and forkhead box protein A2. The most significant pathways involving the 104 DEGs were pathways involved in cancer. Biological process analysis using DAVID, suggested that these genes were associated with the positive regulation of gene expression, gene transcription and metabolic processes. The present study identified a range of genes associated with the development of PTC. The results of the present study were beneficial for understanding the regulatory mechanisms involved in PTC, and for developing clinical diagnostic and therapeutic approaches for this disease.

Entities:  

Mesh:

Year:  2015        PMID: 25586635     DOI: 10.3892/mmr.2015.3180

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  Exploration of the Potential Biomarkers of Papillary Thyroid Cancer (PTC) Based on RT2 Profiler PCR Arrays and Bioinformatics Analysis.

Authors:  Ying Peng; Han-Wen Zhang; Wei-Han Cao; Ying Mao; Ruo-Chuan Cheng
Journal:  Cancer Manag Res       Date:  2020-09-28       Impact factor: 3.989

2.  Circ_0058124 Aggravates the Progression of Papillary Thyroid Carcinoma by Activating LMO4 Expression via Targeting miR-370-3p.

Authors:  Lei Liu; Chaohui Yan; Shudong Tao; Hailing Wang
Journal:  Cancer Manag Res       Date:  2020-10-01       Impact factor: 3.989

3.  Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance.

Authors:  Hongwei Gao; Peirong Bai; Lin Xiao; Mengjia Shen; Qiuxiao Yu; Yuanyuan Lei; Wenting Huang; Xiang Lin; Xinyi Zheng; Tao Wei; Yong Jiang; Feng Ye; Hong Bu
Journal:  J Biol Chem       Date:  2020-06-12       Impact factor: 5.157

4.  Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.

Authors:  Ting Qu; Yan-Ping Li; Xiao-Hong Li; Yan Chen
Journal:  Mol Med Rep       Date:  2016-10-19       Impact factor: 2.952

5.  BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm.

Authors:  Jennifer A Silver; Mariya Bogatchenko; Marc Pusztaszeri; Véronique-Isabelle Forest; Michael P Hier; Ji Wei Yang; Michael Tamilia; Richard J Payne
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-11-06

6.  Hsa_circ_0058129 regulates papillary thyroid cancer development via miR-873-5p/follistatin-like 1 axis.

Authors:  Xiangrong Tan; Jiazheng Zhao; Jianlin Lou; Wen Zheng; Peng Wang
Journal:  J Clin Lab Anal       Date:  2022-04-04       Impact factor: 3.124

7.  Identification of potential functional genes in papillary thyroid cancer by co-expression network analysis.

Authors:  Zeng-Xin Ao; Yuan-Cheng Chen; Jun-Min Lu; Jie Shen; Lin-Ping Peng; Xu Lin; Cheng Peng; Chun-Ping Zeng; Xia-Fang Wang; Rou Zhou; Zhi Chen; Hong-Mei Xiao; Hong-Wen Deng
Journal:  Oncol Lett       Date:  2018-08-14       Impact factor: 2.967

8.  Bioinformatics analysis to screen key genes in papillary thyroid carcinoma.

Authors:  Yuanhu Liu; Shuwei Gao; Yaqiong Jin; Yeran Yang; Jun Tai; Shengcai Wang; Hui Yang; Ping Chu; Shujing Han; Jie Lu; Xin Ni; Yongbo Yu; Yongli Guo
Journal:  Oncol Lett       Date:  2019-11-14       Impact factor: 2.967

9.  Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer.

Authors:  Rui Pang; Ye Xu; Xiaonan Hu; Bo Liu; Jiawei Yu
Journal:  Mol Med Rep       Date:  2020-09-17       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.